個別化医療市場：製品、用途、エンドユーザー別-2025～2030年の世界予測

個別化医療市場は、2023年に5,421億米ドルと評価され、2024年には5,755億米ドルに達すると予測され、CAGR 6.67％で成長し、2030年には8,520億2,000万米ドルに達すると予測されています。

個別化医療（PM）は、医療における変革的アプローチであり、個々の遺伝的、環境的、ライフスタイル的要因に合わせた治療に焦点を当てています。その範囲は、正確な治療計画を立案するために不可欠なゲノミクス、薬理ゲノミクス、高度診断学を包含しています。個別化医療の必要性は、カスタマイズ型治療ソリューションに対する患者の需要の高まり、慢性疾患の有病率の増加、オミクス技術の進歩とともに高まっています。用途セグメントは、標的治療ががん患者に新たな希望を与えるがん領域から、心血管疾患や希少遺伝性疾患まで多岐にわたり、それぞれがこの個別化アプローチから大きな恩恵を受けています。最終用途セグメントには、病院、診断ラボ、研究機関などがあり、いずれもPMを活用して治療成績と業務効率を高めています。

市場の成長を加速させる主要要因には、技術の進歩、研究開発への投資、精密医療への取り組みを促進する有利な規制枠組みなどがあります。しかし、ゲノム配列決定のコスト高、データプライバシーに関する懸念、従来の医療診療にPMを統合することの複雑さなどの課題もあります。バイオマーカー探索のための大規模データセット処理における人工知能や機械学習の統合など、新たな機会も豊富にあり、予測精度や治療効果を高めることができます。

革新的な研究セグメントとしては、費用対効果の高いシーケンシング技術の開発や、マイクロバイオームが薬理ゲノミクスに及ぼす影響の調査などがあります。企業は、PMと遠隔医療を組み合わせたデジタルヘルスソリューションに投資し、包括的で個別化されたケアを遠隔で提供することで、競合を得ることができます。市場情勢は複雑かつ断片的であるにもかかわらず、力強い成長の可能性を秘めています。こうした機会を活用するため、企業は戦略的パートナーシップ、技術統合、患者中心のサービス提供に注力すべきです。市場の性質はダイナミックであり、技術の進歩や規制の変更に伴って急速に進化するため、事業の持続的成長と競合を高めるためには継続的なイノベーションと適応が必要となります。

市場力学：急速に進化する個別化医療市場の主要市場洞察を公開

個別化医療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • バイオテクノロジー研究イニシアチブの増加と遺伝学の理解向上
  • 複雑な疾患を対象とした個別化治療戦略の採用急増
  • 個別化医療への認知度向上とアクセス向上のための政府の支援策
• 市場抑制要因
  • 個別化医療の導入における複雑さと熟練者の不足
• 市場機会
  • 個別化医療の改善に向けた継続的な研究開発活動
  • 個別化医療のバーチャルとデジタル戦略採用の可能性
• 市場課題
  • 限られたアクセシビリティと精度に関する問題

ポーターのファイブフォース：個別化医療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、個別化医療市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：個別化医療市場における外部からの影響の把握

外部マクロ環境要因は、個別化医療市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：個別化医療市場における競合情勢の把握

個別化医療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：個別化医療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、個別化医療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：個別化医療市場における成功への道筋を描く

個別化医療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオ調査の取り組みの増加と遺伝学の理解の向上
    • 複雑な疾患を標的とした個別化治療戦略の導入が急増
    • 個別化医療の認知度とアクセスを高めるための政府の支援活動
  • 抑制要因
    • 個別化医療の実装の複雑さと熟練した人材の不足
  • 機会
    • 個別化医療の改善に向けた継続的な研究開発活動
    • 個別化医療の仮想とデジタル戦略の採用の可能性
  • 課題
    • アクセシビリティの制限と正確性に関する問題
• 市場セグメンテーション分析
  • 製品：パーソナライズされた栄養と健康の導入により、身体の健康と精神の健康に関する意識が高まっている
  • 用途：精密な治療の必要性から神経学における個別化医療の採用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 個別化医療市場：製品別

• イントロダクション
• 個別化医療
  • 医療情報技術
  • 遠隔医療
• 個別化医療診断
  • 消費者直接販売（DTC）診断
  • エソテリックラボサービス
  • エソテリックラボ検査
  • 遺伝子検査
• 個別化治療
  • ゲノム医療
  • 医療機器
  • 製薬
• 個別化栄養と健康
  • 補完代替医療
  • 小売栄養

第7章 個別化医療市場：用途別

• イントロダクション
• 抗ウィルス薬
• 心臓病学
• 免疫学
• 神経学
• 腫瘍学
• 精神医療

第8章 個別化医療市場：エンドユーザー別

• イントロダクション
• 学術研究機関とラボ
• バイオ＆ヘルスインフォマティクス企業
• 契約研究機関
• 診断会社と検査施設
• 病院と臨床ケア

第9章 南北アメリカの個別化医療市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の個別化医療市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの個別化医療市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • AstraZeneca、がん個別化医療のためFusion Pharmaceuticalsを買収
  • CurifyLabsがMehta Heino Industriesから主要な3Dプリンティング IPを取得し、個別化医療ソリューションを進化
  • 戦略的買収によりNovartisの精密医療能力が強化
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Amgen, Inc.
• AstraZeneca
• Bayer Ag
• BIOGEN INC.
• Eli Lilly and Company
• Exact Sciences Corporation
• Exagen Inc
• F. Hoffmann-La Roche Ltd
• GE HealthCare Technologies Inc.
• Glaxosmithkline Plc.
• Illumina, Inc.
• Johnson & Johnson Services, Inc.
• Laboratory Corporation of America Holdings
• Merck & Co., Inc.
• Novartis International AG
• Pfizer Inc.
• Precision Biologics, Inc.
• QIAGEN GmbH
• Takeda Pharmaceutical Company Limited

LIST OF FIGURES

• FIGURE 1. PERSONALIZED MEDICINE MARKET RESEARCH PROCESS
• FIGURE 2. PERSONALIZED MEDICINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PERSONALIZED MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PERSONALIZED MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PERSONALIZED MEDICINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PERSONALIZED MEDICINE MARKET DYNAMICS
• TABLE 7. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HEALTH INFORMATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIRECT-TO-CONSUMER (DTC) DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ESOTERIC LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GENOMIC MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COMPLEMENTARY & ALTERNATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY RETAIL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ANTIVIRAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES & RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY BIO & HEALTH INFORMATICS COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY DIAGNOSTIC COMPANIES & TESTING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY HOSPITALS & CLINICAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 62. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 64. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 65. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 66. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 67. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. CANADA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES PERSONALIZED MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 99. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 101. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 102. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 103. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 104. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. CHINA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 106. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 108. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 109. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 110. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 111. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. INDIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. SINGAPORE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. SOUTH KOREA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. TAIWAN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. THAILAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. VIETNAM PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. DENMARK PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. EGYPT PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. FINLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. FRANCE PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. GERMANY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. ISRAEL PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 226. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 228. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 229. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 230. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 231. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. ITALY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. NETHERLANDS PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. NIGERIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. NORWAY PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 254. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 255. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 256. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 257. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 258. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 259. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. POLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 261. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 263. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 264. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 265. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 266. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. QATAR PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. RUSSIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 281. SAUDI ARABIA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 288. SOUTH AFRICA PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 295. SPAIN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 302. SWEDEN PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICAL CARE, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY PERSONALIZED NUTRITION & WELLNESS, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 309. SWITZERLAND PERSONALIZED MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY PERSONALIZED MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY PERSONALIZED MEDICINE MARKET SIZE, BY PERSONAL

The Personalized Medicine Market was valued at USD 542.10 billion in 2023, expected to reach USD 575.50 billion in 2024, and is projected to grow at a CAGR of 6.67%, to USD 852.02 billion by 2030.

Personalized medicine (PM) represents a transformative approach in healthcare, focusing on tailoring treatments to individual genetic, environmental, and lifestyle factors. Its scope encompasses genomics, pharmacogenomics, and advanced diagnostics, essential for devising precise treatment plans. The necessity of personalized medicine grows with the rising patient demand for customized therapeutic solutions, increased prevalence of chronic diseases, and advancements in omics technologies. Application areas range from oncology, where targeted therapies offer new hope for cancer patients, to cardiovascular diseases and rare genetic disorders, each benefiting significantly from this personalized approach. End-use segments include hospitals, diagnostic labs, and research institutions, all of which leverage PM to enhance treatment outcomes and operational efficiencies.

Key factors accelerating market growth include technological advancements, investment in research and development, and favorable regulatory frameworks promoting precision medicine initiatives. However, there are challenges such as high costs of genomic sequencing, data privacy concerns, and the complexity of integrating PM into traditional healthcare practices. Nevertheless, emerging opportunities abound, such as the integration of artificial intelligence and machine learning in processing large datasets for biomarker discovery, which can enhance predictive accuracy and treatment efficacy.

Innovative research areas include the development of cost-effective sequencing technologies and the exploration of microbiome influence on pharmacogenomics. Businesses can gain a competitive edge by investing in digital health solutions that combine PM with telemedicine, offering comprehensive, personalized care remotely. Despite being a complex and fragmented landscape, the personalized medicine market offers robust growth potential. To harness these opportunities, companies should focus on strategic partnerships, technological integration, and patient-centric approaches to service delivery. The nature of the market is dynamic, evolving rapidly with technological advancements and regulatory changes, necessitating continuous innovation and adaptation for sustained business growth and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Personalized Medicine Market

The Personalized Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in biotechnology research initiatives and improved understanding of genetics
  • Surge in the adoption of personalized treatment strategies for targeting complex diseases
  • Supportive government initiatives to raise awareness for and access to personalized medicine
• Market Restraints
  • Complexities in the implementation of personalized medicine and lack of skilled personnel
• Market Opportunities
  • Ongoing R&D activities for improvements in personalized medicines
  • Potential for the adoption of virtual and digital strategies for personalized medicine
• Market Challenges
  • Limited accessibility and issues related to accuracy

Porter's Five Forces: A Strategic Tool for Navigating the Personalized Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Personalized Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Personalized Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Personalized Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Personalized Medicine Market

A detailed market share analysis in the Personalized Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Personalized Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Personalized Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Personalized Medicine Market

A strategic analysis of the Personalized Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Personalized Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., AstraZeneca, Bayer Ag, BIOGEN INC., Eli Lilly and Company, Exact Sciences Corporation, Exagen Inc, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Glaxosmithkline Plc., Illumina, Inc., Johnson & Johnson Services, Inc., Laboratory Corporation of America Holdings, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Precision Biologics, Inc., QIAGEN GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Personalized Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Personalized Medical Care, Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, and Personalized Nutrition & Wellness. The Personalized Medical Care is further studied across Health Information Technology and Telemedicine. The Personalized Medicine Diagnostics is further studied across Direct-to-consumer (DTC) Diagnostics, Esoteric Lab Services, Esoteric Lab Tests, and Genetic Testing. The Personalized Medicine Therapeutics is further studied across Genomic Medicine, Medical Devices, and Pharmaceutical. The Personalized Nutrition & Wellness is further studied across Complementary & Alternative Medicine and Retail Nutrition.
• Based on Application, market is studied across Antiviral, Cardiology, Immunology, Neurology, Oncology, and Psychiatry.
• Based on End Users, market is studied across Academic Research Institutes & Research Laboratories, Bio & Health Informatics Companies, Contract Research Organizations, Diagnostic Companies & Testing Facilities, and Hospitals & Clinical Care.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in biotechnology research initiatives and improved understanding of genetics
    • 5.1.1.2. Surge in the adoption of personalized treatment strategies for targeting complex diseases
    • 5.1.1.3. Supportive government initiatives to raise awareness for and access to personalized medicine
  • 5.1.2. Restraints
    • 5.1.2.1. Complexities in the implementation of personalized medicine and lack of skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing R&D activities for improvements in personalized medicines
    • 5.1.3.2. Potential for the adoption of virtual and digital strategies for personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Limited accessibility and issues related to accuracy
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing awareness about physical health and mental health owing to the adoption of personalized nutrition & wellness
  • 5.2.2. Application: Increased adoption of personalized medicine in neurology due to the need for precise treatment
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Personalized Medicine Market, by Product

• 6.1. Introduction
• 6.2. Personalized Medical Care
  • 6.2.1. Health Information Technology
  • 6.2.2. Telemedicine
• 6.3. Personalized Medicine Diagnostics
  • 6.3.1. Direct-to-consumer (DTC) Diagnostics
  • 6.3.2. Esoteric Lab Services
  • 6.3.3. Esoteric Lab Tests
  • 6.3.4. Genetic Testing
• 6.4. Personalized Medicine Therapeutics
  • 6.4.1. Genomic Medicine
  • 6.4.2. Medical Devices
  • 6.4.3. Pharmaceutical
• 6.5. Personalized Nutrition & Wellness
  • 6.5.1. Complementary & Alternative Medicine
  • 6.5.2. Retail Nutrition

7. Personalized Medicine Market, by Application

• 7.1. Introduction
• 7.2. Antiviral
• 7.3. Cardiology
• 7.4. Immunology
• 7.5. Neurology
• 7.6. Oncology
• 7.7. Psychiatry

8. Personalized Medicine Market, by End Users

• 8.1. Introduction
• 8.2. Academic Research Institutes & Research Laboratories
• 8.3. Bio & Health Informatics Companies
• 8.4. Contract Research Organizations
• 8.5. Diagnostic Companies & Testing Facilities
• 8.6. Hospitals & Clinical Care

9. Americas Personalized Medicine Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Personalized Medicine Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Personalized Medicine Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. AstraZeneca Acquires Fusion Pharmaceuticals for Personalized Cancer Medicine
  • 12.3.2. CurifyLabs Acquires Key 3D Printing IP from Mehta Heino Industries to Advance Personalized Medicine Solutions
  • 12.3.3. Strategic Acquisition Enhances Novartis' Precision Medicine Capabilities
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Amgen, Inc.
• 3. AstraZeneca
• 4. Bayer Ag
• 5. BIOGEN INC.
• 6. Eli Lilly and Company
• 7. Exact Sciences Corporation
• 8. Exagen Inc
• 9. F. Hoffmann-La Roche Ltd
• 10. GE HealthCare Technologies Inc.
• 11. Glaxosmithkline Plc.
• 12. Illumina, Inc.
• 13. Johnson & Johnson Services, Inc.
• 14. Laboratory Corporation of America Holdings
• 15. Merck & Co., Inc.
• 16. Novartis International AG
• 17. Pfizer Inc.
• 18. Precision Biologics, Inc.
• 19. QIAGEN GmbH
• 20. Takeda Pharmaceutical Company Limited